Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) Short Interest Up 49.3% in May

Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) was the recipient of a large growth in short interest in the month of May. As of May 31st, there was short interest totalling 200,000 shares, a growth of 49.3% from the May 15th total of 134,000 shares. Approximately 1.3% of the company’s shares are short sold. Based on an average daily volume of 209,500 shares, the short-interest ratio is currently 1.0 days.

Inspira Technologies Oxy B.H.N. Stock Down 2.6 %

Shares of NASDAQ:IINN traded down $0.05 during mid-day trading on Friday, reaching $1.90. 91,569 shares of the company were exchanged, compared to its average volume of 208,220. The company has a debt-to-equity ratio of 0.10, a quick ratio of 2.61 and a current ratio of 2.61. The firm’s 50-day simple moving average is $2.06 and its 200 day simple moving average is $1.54. Inspira Technologies Oxy B.H.N. has a 1 year low of $0.76 and a 1 year high of $2.49.

Hedge Funds Weigh In On Inspira Technologies Oxy B.H.N.

An institutional investor recently bought a new position in Inspira Technologies Oxy B.H.N. stock. Armistice Capital LLC purchased a new stake in Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ:IINN) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,528,000 shares of the company’s stock, valued at approximately $1,620,000. Hedge funds and other institutional investors own 12.72% of the company’s stock.

Inspira Technologies Oxy B.H.N. Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.